Skip to menu Skip to content Skip to footer

A Phase III Randomised Clinical Trial Comparing Patient Outcomes of Sentinel Lymph Node Dissection in Endometrial Cancer (ENDO-3PRO trial) (2020-2022)

Experts

Professor Andreas Obermair

NHMRC Leadership Fellow
UQ Centre for Clinical Research
Faculty of Medicine
Andreas Obermair
Andreas Obermair